Published in World J Surg Oncol on August 08, 2014
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
Guideline for management of the clinical T1 renal mass. J Urol (2009) 8.26
EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol (2010) 8.21
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol (2010) 7.70
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol (2008) 5.70
Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol (2008) 5.30
Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol (2007) 5.24
Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc (2000) 4.45
Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J Urol (2009) 3.49
Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol (2013) 2.85
A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol (2006) 2.80
Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol (2003) 2.77
Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind). J Urol (2013) 2.76
Robot-assisted partial nephrectomy: an international experience. Eur Urol (2010) 2.55
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol (2009) 2.41
Histopathologic analysis of peritumoral pseudocapsule and surgical margin status after tumor enucleation for renal cell carcinoma. Eur Urol (2008) 2.17
Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery. Urology (2009) 2.07
Cytology as an alternative to frozen section at the time of nephron-sparing surgery to evaluate surgical margin status. Urology (2013) 2.04
Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Eur Urol (2009) 1.85
Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol (2008) 1.83
Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis. Eur Urol (2010) 1.65
Short-term functional and oncologic outcomes of nephron-sparing surgery for renal tumours ≥ 7 cm. Eur Urol (2011) 1.63
Robot-assisted laparoscopic nephron sparing surgery for tumors over 4 cm: operative results and preliminary oncologic outcomes from a multicentre French study. Eur J Surg Oncol (2013) 1.53
Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol (2010) 1.52
A retrospective comparison of 2 methods of intraoperative margin evaluation during partial nephrectomy. J Urol (2008) 1.49
Laparoscopic partial nephrectomy: a single-center evolving experience. Urology (2009) 1.48
Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol (2012) 1.46
Does tumour size really affect the safety of laparoscopic partial nephrectomy? BJU Int (2010) 1.45
Robot-assisted partial nephrectomy: a large single-institutional experience. Urology (2010) 1.45
Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm. J Urol (2008) 1.35
Positive margins in laparoscopic partial nephrectomy in 855 cases: a multi-institutional survey from the United States and Europe. J Urol (2007) 1.31
Laparoscopic partial nephrectomy for renal masses: effect of tumor location. Urology (2006) 1.27
Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter? J Urol (2002) 1.19
Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. J Urol (2011) 1.19
Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan-Kettering experience. BJU Int (2004) 1.15
Laparoscopic partial nephrectomy for centrally located renal tumors. J Urol (2006) 1.10
Simple enucleation for the treatment of PT1a renal cell carcinoma: our 20-year experience. Eur Urol (2006) 1.10
Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol (2007) 1.08
Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours. BJU Int (2006) 1.08
Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma. Urology (2002) 1.07
Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J Urol (2005) 1.05
Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology (2006) 1.05
Positive surgical parenchymal margin after laparoscopic partial nephrectomy for renal cell carcinoma: oncological outcomes. J Urol (2006) 0.95
Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma. Ann Surg Oncol (2011) 0.94
Open partial nephrectomy: outcomes from two UK centres. BJU Int (2006) 0.93
Comparison of laparoscopic and open partial nephrectomy in clinical T1a renal tumors. J Endourol (2008) 0.92
Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy. Urology (2012) 0.92
Positive surgical margins after nephron-sparing surgery. Eur Urol (2011) 0.91
Comparison of hilar clamping and non-hilar clamping partial nephrectomy for tumours involving a solitary kidney. BJU Int (2010) 0.91
Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma. Eur Urol (2010) 0.89
Partial nephrectomy using porcine small intestinal submucosa. World J Surg Oncol (2011) 0.89
Impact of elective versus imperative indications on oncologic outcomes after open nephron-sparing surgery for the treatment of sporadic renal cell carcinomas. Ann Surg Oncol (2010) 0.89
Simple enucleation versus standard partial nephrectomy for clinical T1 renal masses: perioperative outcomes based on a matched-pair comparison of 396 patients (RECORd project). Eur J Surg Oncol (2014) 0.88
Assessment of surgical margins in renal cell carcinoma after nephron sparing: a comparative study: laparoscopy vs open surgery. J Urol (2005) 0.87
Prevalence and impact on survival of positive surgical margins in partial nephrectomy for renal cell carcinoma: a population-based study. BJU Int (2013) 0.86
Small renal cell carcinomas--how dangerous are they really? Results of a large multicenter study. Eur J Cancer (2013) 0.85
Local recurrence after tumour enucleation for renal cell carcinoma with no ablation of the tumour bed: results of a prospective single-centre study. BJU Int (2010) 0.85
Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications. Ann Surg Oncol (2009) 0.83
Is frozen section analysis in nephron sparing surgery necessary? A clinicopathological study of 301 cases. J Urol (2005) 0.83
Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer (2012) 0.82
Utility of intraoperative frozen section during robot-assisted partial nephrectomy: a single institution experience. J Endourol (2013) 0.82
Long-term results of nephron-sparing surgery for renal cell carcinoma in 114 patients: risk factors for progressive disease. BJU Int (2003) 0.80
Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys. World J Urol (2010) 0.79
The impact of frozen section analysis during partial nephrectomy on surgical margin status and tumor recurrence: a clinicopathologic study of 433 cases. Clin Genitourin Cancer (2013) 0.78
A comparison of pathologic outcomes of matched robotic and open partial nephrectomies. Int Urol Nephrol (2013) 0.78
Is there a benefit to frozen section analysis at the time of partial nephrectomy? Can J Urol (2013) 0.77
Positive margin during partial nephrectomy: does cancer remain in the renal remnant? Urology (2011) 0.77
[Update Urooncology: News with clinical relevance from major scientific meetings 2013]. Aktuelle Urol (2014) 0.76
Renal artery occlusion during nephron-sparing surgery: retrospective review of 301 cases. Urology (2006) 0.76
Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxel. Anticancer Drugs (2006) 1.28
Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma. Eur J Cancer (2012) 1.08
Potential clinical implications of BRAF mutations in histiocytic proliferations. Oncotarget (2014) 1.07
Localization of FOXP3-positive cells in renal cell carcinoma. Tumour Biol (2011) 1.05
An SK3 channel/nWASP/Abi-1 complex is involved in early neurogenesis. PLoS One (2011) 0.98
Heterogeneous nuclear ribonucleoprotein k interacts with Abi-1 at postsynaptic sites and modulates dendritic spine morphology. PLoS One (2011) 0.92
Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer. BJU Int (2006) 0.89
Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection. PLoS One (2013) 0.89
Neoadjuvant therapy of renal cell carcinoma: a novel treatment option in the era of targeted therapy? Int J Urol (2012) 0.89
Comparison of a 20-min pad test with the 1-hour pad test of the international continence society to evaluate post-prostatectomy incontinence. Urol Int (2009) 0.89
Morbidity and Quality of Life in Bladder Cancer Patients following Cystectomy and Urinary Diversion: A Single-Institution Comparison of Ileal Conduit versus Orthotopic Neobladder. ISRN Urol (2012) 0.88
Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinoma. BMC Cancer (2013) 0.87
Serum C-reactive protein: a prognostic factor in metastatic urothelial cancer of the bladder. Med Oncol (2013) 0.83
Biochemical markers for monitoring response to therapy: evidence for higher bone specificity by a novel marker compared with routine markers. Cancer Epidemiol Biomarkers Prev (2008) 0.82
In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall. Anticancer Res (2009) 0.82
Frequency and gene expression profile of regulatory T cells in renal cell carcinoma. Tumour Biol (2009) 0.82
Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size. Virchows Arch (2014) 0.81
GSTP1 CpG island hypermethylation for DNA-based detection of occult tumor cells in surgical margins after radical prostatectomy. World J Urol (2011) 0.80
The "Aging Males' Symptoms" Scale (AMS): predictive value for lowered circulating androgens. Aging Male (2012) 0.80
Laparoscopic peritoneal drainage of symptomatic lymphoceles after pelvic lymph node dissection using methylene blue instillation. Urol Int (2006) 0.80
Detection of circulating tumor cells in patients with renal cell carcinoma by reverse transcriptase polymerase chain reaction for G250/MNCA-9: results of a prospective trial. Urol Oncol (2006) 0.80
Corpulence is the crucial factor: association of testosterone and/or obesity with prostate cancer stage. Int J Urol (2014) 0.78
Renal Cell Carcinoma Update: News from the AUA, EAU, and ASCO Annual Meetings 2011. ISRN Urol (2012) 0.78
Arteriolar vascular smooth muscle cell differentiation in benign nephrosclerosis. Nephrol Dial Transplant (2012) 0.77
The retrourethral transobturator sling suspension in the treatment of male urinary stress incontinence: results of a single institution experience. ISRN Urol (2012) 0.77
Role of reflux-induced epithelial-mesenchymal transition in periprosthetic leakage after prosthetic voice rehabilitation. Head Neck (2014) 0.76
Expression and functional influence of cellular retinoic acid-binding protein II in renal cell carcinoma. Urol Int (2005) 0.75
Capsulotomy for treatment of compartment syndrome in patients with post extracorporeal shock wave lithotripsy renal hematomas: safe and effective, but also advisable? Urol J (2014) 0.75
Trophoblast Cell Surface Antigen 2 (Trop2) in Chromophobe Renal Cell Carcinoma. Oncology (2022) 0.75
Do preoperative serum C-reactive protein levels predict the definitive pathological stage in patients with clinically localized prostate cancer? Int Urol Nephrol (2015) 0.75